Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Methods Mol Biol. 2024;2779:425-456. doi: 10.1007/978-1-0716-3738-8_20.
The emergence of new pathogens continues to fuel the need for advanced high-containment laboratories across the globe. Here we explore challenges and opportunities for integration of cytometry, a central technology for cell analysis, within high-containment laboratories. We review current applications in infectious disease, vaccine research, and biosafety. Considerations specific to cytometry within high-containment laboratories, such as biosafety requirements, and sample containment strategies are also addressed. We further tour the landscape of emerging technologies, including combination of cytometry with other omics, the application of automation, and artificial intelligence. Finally, we propose a framework to fast track the immersion of advanced technologies into the high-containment research setting to improve global preparedness for new emerging diseases.
新病原体的不断出现继续推动着全球对高级高防护实验室的需求。在这里,我们探讨了在高防护实验室中整合细胞分析核心技术——流式细胞术的挑战和机遇。我们回顾了其在传染病、疫苗研究和生物安全领域的当前应用。还讨论了高防护实验室中流式细胞术的特殊考虑因素,如生物安全要求和样本隔离策略。我们进一步探讨了新兴技术的发展趋势,包括流式细胞术与其他组学的结合、自动化的应用和人工智能。最后,我们提出了一个框架,以加速将先进技术融入高防护研究环境中,从而提高全球对新出现疾病的应对能力。